Grifols, S.A. Company Profile (NASDAQ:GRFS)

About Grifols, S.A. (NASDAQ:GRFS)

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Symbol: NASDAQ:GRFS
CUSIP: N/A
Web: www.grifols.com

Capitalization:

Market Cap: $14.13444 billion
Outstanding Shares: 1,339,930,000

Average Prices:

50 Day Moving Avg: $21.15
200 Day Moving Avg: $19.39
52 Week Range: $14.27 - $22.83

P/E:

Trailing P/E Ratio: 43.34
Foreward P/E Ratio: 15.67
P/E Growth: 1.29

Sales & Book Value:

Annual Revenue: $4.77 billion
Price / Sales: 5.72
Book Value: $3.26 per share
Price / Book: 6.25

Dividend:

Annual Dividend: $0.28
Dividend Yield: 1.3%

Profitability:

EBIDTA: $1.31 billion
Net Margins: 13.36%
Return on Equity: 17.87%
Return on Assets: 6.52%

Debt:

Debt-to-Equity Ratio: 1.26%
Current Ratio: 2.91%
Quick Ratio: 1.38%

Misc:

Average Volume: 667,275 shs.
Beta: 0.98
Short Ratio: 2.01

Frequently Asked Questions for Grifols, S.A. (NASDAQ:GRFS)

What is Grifols, S.A.'s stock symbol?

Grifols, S.A. trades on the NASDAQ under the ticker symbol "GRFS."

How often does Grifols, S.A. pay dividends? What is the dividend yield for Grifols, S.A.?

Grifols, S.A. announced a semiannual dividend on Friday, May 26th. Stockholders of record on Thursday, June 1st will be paid a dividend of $0.122 per share on Thursday, June 8th. This represents a dividend yield of 1.54%. The ex-dividend date is Tuesday, May 30th. View Grifols, S.A.'s Dividend History.

When did Grifols, S.A.'s stock split? How did Grifols, S.A.'s stock split work?

Grifols, S.A. shares split on the morning of Monday, January 4th 2016. The 2-1 split was announced on Thursday, December 3rd 2015. The newly minted shares were distributed to shareholders after the closing bell on Thursday, December 31st 2015. An investor that had 100 shares of Grifols, S.A. stock prior to the split would have 200 shares after the split.

Who are some of Grifols, S.A.'s key competitors?

Some companies that are related to Grifols, S.A. include Jazz Pharmaceuticals PLC (JAZZ), SIGA Technologies (SIGA), Osiris Therapeutics (OSIR), VBI Vaccines (VBIV), Anavex Life Sciences Corp. (AVXL), Mirati Therapeutics (MRTX), XOMA Corporation (XOMA), ContraFect Corporation (CFRX), Aevi Genomic Medicine (GNMX), Trillium Therapeutics (TRIL), Ohr Pharmaceuticals (OHRP), Can Fite Biopharma Ltd (CANF), KaloBios Pharmaceuticals (KBIO), Mateon Therapeutics (MATN), Windtree Therapeutics (WINT), Affymax (AFFY), Cubist Pharmaceuticals (CBST) and Dendreon (DNDN).

Who owns Grifols, S.A. stock?

Grifols, S.A.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.20%), Gladstone Capital Management LLP (0.07%), Aperio Group LLC (0.02%), US Bancorp DE (0.01%), CWM LLC (0.01%) and Bank of Montreal Can (0.01%). View Institutional Ownership Trends for Grifols, S.A..

Who sold Grifols, S.A. stock? Who is selling Grifols, S.A. stock?

Grifols, S.A.'s stock was sold by a variety of institutional investors in the last quarter, including Gladstone Capital Management LLP, US Bancorp DE, Independent Portfolio Consultants Inc., OLD National Bancorp IN and Huntington National Bank. View Insider Buying and Selling for Grifols, S.A..

Who bought Grifols, S.A. stock? Who is buying Grifols, S.A. stock?

Grifols, S.A.'s stock was acquired by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Aperio Group LLC, CWM LLC, BB&T Corp, Atria Investments LLC and Bank of Montreal Can. View Insider Buying and Selling for Grifols, S.A..

How do I buy Grifols, S.A. stock?

Shares of Grifols, S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Grifols, S.A.'s stock price today?

One share of Grifols, S.A. stock can currently be purchased for approximately $20.37.

MarketBeat Community Rating for Grifols, S.A. (NASDAQ GRFS)

Community Ranking:		1.8 out of 5 ()
Outperform Votes:		65 (Vote Outperform)
Underperform Votes:		113 (Vote Underperform)
Total Votes:		178

MarketBeat's community ratings are surveys of what our community members think about Grifols, S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Grifols, S.A. (NASDAQ:GRFS) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Sell Rating, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:	Hold (Score: 2.25)
Consensus Price Target:	N/A

Analysts' Ratings History for Grifols, S.A. (NASDAQ:GRFS)

Show:

Date	Firm	Action	Rating	Impact on Share Price
7/4/2017	Bank of America Corporation	Reiterated Rating	Buy	Medium
6/30/2017	Goldman Sachs Group, Inc. (The)	Downgrade	Buy -> Neutral	Low
4/7/2017	HSBC Holdings plc	Downgrade	Hold -> Reduce	Medium
3/30/2017	J P Morgan Chase & Co	Upgrade	Neutral -> Overweight	High
6/6/2016	Morgan Stanley	Reiterated Rating	Sell	N/A
3/17/2016	Nomura	Initiated Coverage	Buy	N/A
2/9/2016	Berenberg Bank	Upgrade	Hold -> Buy	N/A

(Data available from 7/25/2015 forward)

Earnings History for Grifols, S.A. (NASDAQ:GRFS)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Grifols, S.A. (NASDAQ:GRFS)

2017 EPS Consensus Estimate: $1.13
2018 EPS Consensus Estimate: $1.26

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	1	$0.26	$0.26	$0.26
Q2 2017	1	$0.28	$0.28	$0.28
Q3 2017	1	$0.28	$0.28	$0.28
Q4 2017	1	$0.31	$0.31	$0.31
Q1 2018	1	$0.29	$0.29	$0.29
Q2 2018	1	$0.32	$0.32	$0.32
Q3 2018	1	$0.31	$0.31	$0.31
Q4 2018	1	$0.34	$0.34	$0.34

(Data provided by Zacks Investment Research)

Current Dividend Information for Grifols, S.A. (NASDAQ:GRFS)

Most Recent Dividend:	6/8/2017
Annual Dividend:	$0.28
Dividend Yield:	1.37%
Payout Ratio:	30.77% (Trailing 12 Months of Earnings) 24.14% (Based on This Year's Estimates) 21.54% (Based on Next Year's Estimates)

Dividend Payments by Quarter for Grifols, S.A. (NASDAQ:GRFS)

Dividend History by Quarter for Grifols, S.A. (NASDAQ GRFS)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/26/2017	semiannual	$0.12	1.54%	5/30/2017	6/1/2017	6/8/2017
11/22/2016		$0.15		12/5/2016	12/7/2016	12/7/2016
5/31/2016		$0.11		6/2/2016	6/6/2016	6/6/2016
12/1/2015		$0.30		12/10/2015	12/14/2015	12/14/2015

(Data available from 1/1/2013 forward)

Insider Trading History for Grifols, S.A. (NASDAQ:GRFS)
No insider trades for this company have been tracked by MarketBeat.com

Headline Trends for Grifols, S.A. (NASDAQ:GRFS) Latest Headlines for Grifols, S.A. (NASDAQ:GRFS)

Source:

Date	Headline
	Grifols, S.A. (NASDAQ:GRFS) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - July 19 at 12:16 AM
	Grifols, S.A. (GRFS) Lowered to Sell at BidaskClub www.americanbankingnews.com - July 5 at 9:54 PM
	Grifols, S.A. (GRFS) Cut to Neutral at Goldman Sachs Group, Inc. (The) www.americanbankingnews.com - June 30 at 10:56 AM
	Grifols, S.A. (GRFS) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - June 24 at 12:50 AM
	Grifols, S.A. (GRFS) Lifted to "Buy" at BidaskClub www.americanbankingnews.com - June 23 at 9:00 PM
	Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples finance.yahoo.com - June 23 at 2:27 AM
	Interesting GRFS Put And Call Options For February 2018 - Nasdaq ... - Nasdaq www.nasdaq.com - June 21 at 7:11 PM
	When 'New' Means A Stock Hasn't Led The Market In A While finance.yahoo.com - June 21 at 7:11 PM
	Should Value Investors Consider Grifols (GRFS) Stock Right Now? - Nasdaq www.nasdaq.com - June 16 at 6:16 PM
	Should Value Investors Consider Grifols (GRFS) Stock Right Now? finance.yahoo.com - June 16 at 6:16 PM
	Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement finance.yahoo.com - June 12 at 6:20 PM
	Grifols SA, Barcelona (GRFS) Downgraded by BidAskClub www.americanbankingnews.com - June 10 at 8:38 AM
	Grifols SA, Barcelona (GRFS) Sees Significant Increase in Short Interest www.americanbankingnews.com - June 2 at 9:14 AM
	Grifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017 finance.yahoo.com - May 31 at 5:28 PM
	Grifols SA, Barcelona (GRFS) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - May 29 at 10:48 PM
	Grifols SA, Barcelona Announces Dividend of $0.12 (grfs) www.americanbankingnews.com - May 29 at 10:30 AM
	Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents finance.yahoo.com - May 10 at 5:39 PM
	Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US finance.yahoo.com - May 9 at 12:46 PM
	Grifols SA, Barcelona (GRFS) to Post Q2 2017 Earnings of $0.28 Per Share, William Blair Forecasts www.americanbankingnews.com - May 8 at 8:21 AM
	Zacks Investment Research Downgrades Grifols SA, Barcelona (GRFS) to Hold www.americanbankingnews.com - May 5 at 11:26 PM
	Grifols SA, Barcelona (GRFS) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - May 5 at 11:16 PM
	Q2 2018 EPS Estimates for Grifols SA, Barcelona Decreased by Analyst (GRFS) www.americanbankingnews.com - May 5 at 6:08 PM
	VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y finance.yahoo.com - May 4 at 12:03 PM
	Grifols SA, Barcelona (GRFS) Receives News Impact Score of 0.25 www.americanbankingnews.com - May 4 at 1:23 AM
	Grifols SA, Barcelona (GRFS) Receives News Impact Score of 0.25 www.americanbankingnews.com - May 4 at 1:23 AM
	Grifols SA, Barcelona (GRFS) Receives Consensus Rating of "Hold" from Brokerages www.americanbankingnews.com - May 3 at 12:28 AM
	Grifols SA, Barcelona (GRFS) Receives Daily Media Sentiment Rating of 0.31 www.americanbankingnews.com - April 29 at 12:50 AM
	Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View finance.yahoo.com - April 27 at 6:08 PM
	Grifols SA, Barcelona (GRFS) Receives News Sentiment Score of 0.29 www.americanbankingnews.com - April 25 at 8:12 PM
	Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility finance.yahoo.com - April 24 at 5:17 PM
	Grifols SA, Barcelona (GRFS) Earning Somewhat Favorable News Coverage, Study Finds www.americanbankingnews.com - April 22 at 2:51 PM
	GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% finance.yahoo.com - April 20 at 11:58 AM
	Nivalis' (NVLS) Shares Down After Merger Deal with Alpine finance.yahoo.com - April 20 at 11:58 AM
	Can young blood pump new life into treatments for diseases of aging? finance.yahoo.com - April 19 at 5:24 PM
	Grifols SA, Barcelona (GRFS) Earning Positive News Coverage, Study Shows www.americanbankingnews.com - April 18 at 4:44 PM
	Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program finance.yahoo.com - April 17 at 11:12 AM
	Grifols SA, Barcelona (GRFS) Downgraded to "Reduce" at HSBC Holdings plc www.americanbankingnews.com - April 7 at 7:26 PM
	Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 finance.yahoo.com - April 7 at 10:07 AM
	Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk finance.yahoo.com - April 7 at 10:07 AM
	Amgen Files for Xgeva Label Expansion, To Include Myeloma finance.yahoo.com - April 7 at 10:07 AM
	Grifols SA, Barcelona (GRFS) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - April 6 at 5:10 PM
	Grifols SA, Barcelona (GRFS) Earns Buy Rating from Analysts at Bank of America Corp www.americanbankingnews.com - April 6 at 2:16 PM
	Grifols SA, Barcelona (GRFS) Stock Rating Upgraded by JPMorgan Chase & Co. www.americanbankingnews.com - April 5 at 9:04 AM
	Grifols SA, Barcelona (GRFS) Lifted to Overweight at JPMorgan Chase & Co. www.americanbankingnews.com - March 30 at 12:28 PM
	Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% finance.yahoo.com - March 28 at 11:33 AM
	Is Grifols a Great Stock for Value Investors? finance.yahoo.com - March 17 at 5:48 PM
	Should You Get Rid of USANA Health Sciences (USNA) Now? www.zacks.com - March 6 at 8:58 AM
	Hologic Completes Divestiture of Blood Screening Business finance.yahoo.com - January 31 at 6:09 PM
	Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million finance.yahoo.com - January 31 at 6:09 PM
	Grifols, S.A. upgraded by JP Morgan finance.yahoo.com - January 3 at 8:04 PM

Grifols, S.A. (GRFS) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff

Grifols, S.A. Company Profile (NASDAQ:GRFS)

About Grifols, S.A. (NASDAQ:GRFS)

What is Grifols, S.A.'s stock symbol?

How often does Grifols, S.A. pay dividends? What is the dividend yield for Grifols, S.A.?

When did Grifols, S.A.'s stock split? How did Grifols, S.A.'s stock split work?

Who are some of Grifols, S.A.'s key competitors?

Who owns Grifols, S.A. stock?

Who sold Grifols, S.A. stock? Who is selling Grifols, S.A. stock?

Who bought Grifols, S.A. stock? Who is buying Grifols, S.A. stock?

How do I buy Grifols, S.A. stock?

What is Grifols, S.A.'s stock price today?

Analyst Ratings

Earnings

Estimates

Dividends

Insider Trades

Headlines

Social

Chart